Bornea, Baby Boy .
HRN: 21-94-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CEFOTAXIME 500MG (VIAL)
09/21/2022
09/27/2022
IV
320mg
Q12
NEC
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes